Pleural effusion in interstitial lung disease

Current Opinion in Pulmonary Medicine

Volumn 10, Issue 5, 2004, Pages 390-396

  Highland, Kristin B ^a   Heffner, John E ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Department of Medicine   (United States)

Author keywords

Connective tissue disease; Drug induced lung disease; Idiopathic pulmonary fibrosis; Interstitial lung disease; Pleural effusions; Sarcoidosis

Indexed keywords

AMIODARONE; ANTIINFECTIVE AGENT; BLEOMYCIN; CHLORPROMAZINE; ERGOT DERIVATIVE; HYDRALAZINE; INTERLEUKIN 2; METHOTREXATE; METHYLDOPA; MITOMYCIN; NITROFURANTOIN; PROCAINAMIDE; PROCARBAZINE; TRYPTOPHAN;

AMYLOIDOSIS; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTIOCYTOSIS X; HUMAN; IMAGING SYSTEM; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG FIBROSIS; LUNG GRANULOMA; LUNG PARENCHYMA; LYMPHANGIOMYOMA; LYMPHANGITIS; MIXED CONNECTIVE TISSUE DISEASE; PH; PLEURA BIOPSY; PLEURA EFFUSION; POLYMYOSITIS; PREVALENCE; REVIEW; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 4143107892     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcp.0000134390.27904.a9     Document Type: Review

References (94)

1. Um MK, Im JG, Ahn JM, et al.: Idiopathic pulmonary fibrosis vs. pulmonary involvement of collagen vascular disease: HRCT findings. J Korean Med Sci 1997, 12:492-498.
2. Remy-Jardin M, Beuscart R, Sault MC, et al.: Subpleural micronodules in diffuse infiltrative lung diseases: evaluation with thin-section CT scans. Radiology 1990, 177:133-139.
3. Brauner MW, Grenier P, Mompoint D, et al.: Pulmonary sarcoidosis: evaluation with high-resolution CT. Radiology 1989, 172:467-471.
4. Ohmichi M, Hiraga Y, Hirasawa M: Pulmonary involvements of sarcoidosis. Nihon Kyobu Shikkan Gakkai Zasshi 1990, 28:48-55.
5. Triebel HJ, Kanzow G, Heller M, et al.: The importance of thoracic CT in the diagnosis of pulmonary sarcoidosis. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1990, 153:557-564.
6. Soskel NT, Sharma OP: Pleural involvement in sarcoidosis. Curr Opin Pulm Med 2000, 6:455-468.
7. Johns CJ, Michele TM: The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore) 1999, 78:65-111.
8. Kirks DR, McCormick VD, Greenspan RH: Pulmonary sarcoidosis. Roentgenologic analysis of 150 patients. Am J Roentgenol Radium Ther Nucl Med 1973, 117:777-786.
9. Claiborne RA, Kerby GR: Pleural sarcoidosis with massive effusion and lung entrapment. Kans Med 1990, 91:103-105.
10. Krawczyk I, Sedlaczek AM: A case of sarcoidosis with massive pleural and pericardial effusion. Pneumonol Alergol Pol 1997, 65:81-85.
11. Schmidt RJ, Bender FH, Chang WW, Teba L: Sarcoidosis after renal transplantation. Transplantation 1999, 68:1420-1423.
12. Soskel NT, Sharma OP: Pleural involvement in sarcoidosis: case presentation and detailed review of the literature. Semin Respir Med 1992, 13:492-514.
13. Takahashi N, Enomoto T, Hagiwara T, et al.: A case of sarcoidosis presenting with Heerfordt's syndrome, associated with hepatosplenomegaly, pleural effusion, and ascites. Nihon Kyobu Shikkan Gakkai Zasshi 1992, 30:684-688.
14. Ohmori H, Kajiki A, Miyazaki N, et al.: A case of sarcoidosis complicated by pleural effusion. Nihon Kyobu Shikkan Gakkai Zasshi 1988, 26:1092-1095.
15. Groman GS, Castele RJ, Altose MD, et al.: Lymphocyte subpopulations in sarcoid pleural effusion. Ann Intern Med 1984, 100:75-77.
16. Flammang d'Ortho MP, Cadranel J, Milleron BJ, Akoun GM: Pleural, alveolar and blood T-lymphocyte subsets in pleuropulmonary sarcoidosis. Chest 1990, 98:782-783.
17. Tudela P, Haro M, Marti S, Roig J: Eosinophilic pleuritis as the presenting form of sarcoidosis. Med Clin (Barc) 1992, 99:558.
18. Jarman PR, Whyte MK, Sabroe I, Hughes JM: Sarcoidosis presenting with chylothorax. Thorax 1995, 50:1324-1325.
19. Carlier ML, Roux JP, Perez T, et al.: Chylothorax and sarcoidosis. Rev Mal Respir 1997, 14:315-317.
20. van der Werf TS, Vennik PH: Rare presentation or lead time bias in pleural sarcoidosis? Thorax 1997, 52:752.
21. Horler AR, Thompson M: The pleural and pulmonary complications of rheumatoid arthritis. Ann Intern Med 1959, 50:1179-1203.
22. Anaya JM, Diethelm L, Ortiz LA, et al.: Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 1995, 24:242-254.
23. Sahn SA: The pathophysiology of pleural effusions. Annu Rev Med 1990, 41:7-13.
24. Lillington GA, Carr DT, Mayne JG: Rheumatoid pleurisy with effusion. Arch Intern Med 1971, 128:764-768.
25. Joseph J, Sahn SA: Connective tissue diseases and the pleura. Chest 1993, 104:262-270.
26. Sahn SA, Kaplan RL, Maulitz RM, Good JT Jr: Rheumatoid pleurisy. Observations on the development of low pleural fluid pH and glucose level. Arch Intern Med 1980, 140:1237-1238.
27. Stanek KA, Mills KA: Pleural effusion with rheumatoid arthritis. S D J Med 1991, 44:61-63.
28. Yigla M, Simsolo C, Goralnik L, et al.: The problem of empyematous pleural effusion in rheumatoid arthritis: report of two cases and review of the literature. Clin Rheumatol 2002, 21:180-183. Clear update of the problem with pleural infections in patients with rheumatoid pleurisy.
29. Ocana I, Ribera E, Martinez-Vazquez JM, et al.: Adenosine deaminase activity in rheumatoid pleural effusion. Ann Rheum Dis 1988, 47:394-397.
30. Bonet M, Maymo J, Arnau D, et al.: Adenosine deaminase activity in rheumatoid pleural effusion. Ann Rheum Dis 1989, 48:789.
31. Soderblom T, Pettersson T, Nyberg P, et al.: High pleural fluid hyaluronan concentrations in rheumatoid arthritis. Eur Respir J 1999, 13:519-522.
32. Halla JT, Schrohenloher RE, Volanakis JE: Immune complexes and other laboratory features of pleural effusions: a comparison of rheumatoid arthritis, systemic lupus erythematosus, and other diseases. Ann Intern Med 1980, 92:748-752.
33. Aru A, Engel U, Francis D: Characteristic and specific histological findings in rheumatoid pleurisy. Acta Pathologica, Microbiologica, et Immunologica Scandinavica-Section A. Pathology (Phila) 1986, 94:57-62.
34. Chou CW, Chang SC: Pleuritis as a presenting manifestation of rheumatoid arthritis: diagnostic clues in pleural fluid cytology. Am J Med Sci 2002, 323:158-161. Interesting review that highlights the pleural fluid findings that assist clinicians in confirming a diagnosis of rheumatoid pleurisy.
35. Garcia-Zamalloa A, Ruiz-Irastorza G, Aguayo FJ, Gurrutxaga N: Pseudochylothorax. Report of 2 cases and review of the literature. Medicine (Baltimore) 1999, 78:200-207.
36. Dawson JK, Fewins HE, Desmond J, et al.: Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 2001, 56:622-627.
37. Flatley F: Rheumatoid pulmonary disease. N Engl J Med 1959, 261:1105-1108.
38. Orens JB, Martinez FJ, Lynch JP 3rd: Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1994, 20:159-193.
39. Keane MP, Lynch JP 3rd: Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000, 55:159-166.
40. Good JT Jr, King TE, Antony VB, Sahn SA: Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest 1983, 84:714-718.
41. Carel RS, Shapiro MS, Cordoba O, et al.: LE cells in pleural fluid. Arthritis & Rheumatism 1979, 22:936-937.
42. Mathlouthi A, Ben M'rad S, Merai S, et al.: Massive pleural effusion in systemic lupus erythematosus: thoracoscopic and immunohistological findings. Monaldi Arch Chest Dis 1998, 53:34-36.
43. Turner-Stokes L, Haslam P, Jones M, et al.: Autoantibody and idiotype profile of lung involvement in autoimmune rheumatic disease. Ann Rheum Dis 1990, 49:160-162.
44. Winslow WA, Plossm LN, Loitman B: Pleuritis in systemic lupus erythematosus: importance as an early manifestation in diagnosis. Ann Intern Med 1958, 9:70-88.
45. Wang DY: Diagnosis and management of lupus pleuritis. Curr Opin Pulm Med 2002, 8:312-316. Excellent comprehensive review of lupus pleuritis with emphasis on the clinical, radiographic, and pleural fluid features of the condition.
46. Fenlon HM, Doran M, Sant SM, Breatnach E: High-resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol 1996, 166:301-307.
47. Bankier AA, Kiener HP, Wiesmayr MN, et al.: Discrete lung involvement in systemic lupus erythematosus: CT assessment. Radiology 1995, 196:835-840.
48. Ooi GC, Ngan H, Peh WC, et al.: Systemic lupus erythematosus patients with respiratory symptoms: the value of HRCT. Clin Radiol 1997, 52:775-781.
49. Weaver AL, Divertie MB, Titus JL: Pulmonary scleroderma. Dis Chest 1968, 54:490-498.
50. Weaver AL, Divertie MB, Titus JL: The lung scleroderma. Mayo Clin Proc 1967, 42:754-766.
51. Maeshima E, Nishimoto T, Yamashita M, et al.: Progressive systemic sclerosis-polymyositis overlap syndrome with eosinophilic pleural effusion. Rheumatol Int 2003, 23:252-254. Case report highlighting an unusual manifestation of pleural disease in systemic sclerosis-polymyositis overlap syndrome.
52. Thompson AE, Pope JE: A study of the frequency of pericardial and pleural effusions in scleroderma. Br J Rheumatol 1998, 37:1320-1323.
53. Kimura K, Ezoe K, Yokozeki H, et al.: Elevated serum CA125 in progressive systemic sclerosis with pleural effusion. J Dermatol 1995, 22:28-31.
54. Mino M, Noma S, Taguchi Y, et al.: Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT. AJR Am J Roentgenol 1997, 169:83-87.
55. Miyata M, Fukaya E, Takagi T, et al.: Two patients with polymyositis or dermatomyositis complicated with massive pleural effusion. Intern Med 1998, 37:1058-1063.
56. Prakash UB: Respiratory complications in mixed connective tissue disease. Clin Chest Med 1998, 19:733-746.
57. Prakash UB: Lungs in mixed connective tissue disease. J Thorac Imaging 1992, 7:55-61.
58. Morelock SY, Sahn SA: Drugs and the pleura. Chest 1999, 116:212-221.
59. Holmberg L, Boman G: Pulmonary reactions to nitrofurantoin. 447 cases reported to the Swedish Adverse Drug Reaction Committee 1966-1976. Eur J Respir Dis 1981, 62:180-189.
60. Rosenow EC 3rd: Drug-induced bronchopulmonary pleural disease. J Allergy Clin Immunol 1987, 80:780-787.
61. Geller M, Flaherty DK, Dickie HA, Reed CE: Lymphopenia in acute nitrofurantoin pleuropulmonary reactions. J Allergy Clin Immunol 1977, 59:445-448.
62. Cooper JA Jr, White DA, Matthay RA: Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs. Am Rev Respir Dis 1986, 133:488-505.
63. Imokawa S, Colby W, Leslie KO, Helmers RA: Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000, 15:373-381.
64. Ecker MD, Jay B, Keohane MF: Procarbazine lung. AJR Am J Roentgenol 1978, 131:527-528.
65. Beck JM: Pleural disease in patients with acquired immune deficiency syndrome. Clin Chest Med 1998, 19:341-349.
66. Gunstream SR, Seidenfeld JJ, Sobonya RE, McMahon LJ: Mitomycin-associated lung disease. Cancer Treat Rep 1983, 67:301-304.
67. Vogelzang PJ, Bloom SM, Mier JW, Atkins MB: Chest roentgenographic abnormalities in IL-2 recipients. Incidence and correlation with clinical parameters. Chest 1992, 101:746-752.
68. Saxon RR, Klein JS, Bar MH, et al.: Pathogenesis of pulmonary edema during interleukin-2 therapy: correlation of chest radiographic and clinical findings in 54 patients. AJR Am J Roentgenol 1991, 156:281-285.
69. Pfitzenmeyer P, Foucher P, Dennewald G, et al.: Pleuropulmonary changes induced by ergoline drugs. Eur Respir J 1996, 9:1013-1019.
70. McElvaney NG, Wilcox PG, Churg A, Fleetham JA: Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease. Arch Intern Med 1988, 148:2231-2236.
71. Gonzalez-Rothi RJ, Hannan SE, Hood CI, Franzini DA: Amiodarone pulmonary toxicity presenting as bilateral exudative pleural effusions. Chest 1987, 92:179-182.
72. Stein B, Zaatari GS, Pine JR: Amiodarone pulmonary toxicity. Clinical, cytologic and ultrastructural findings. Acta Cytol 1987, 31:357-361.
73. Akoun GM, Milleron BJ, Badaro DM, et al.: Pleural T-lymphocyte subsets in amiodarone-associated pleuropneumonitis. Chest 1989, 95:596-597.
74. Shore ET: L-tryptophan induced cough and pleural effusions associated with the eosinophilia-myalgia syndrome. Chest 1990, 98:1540.
75. De Groot RE, Willems LN, Dijkman JH: Interstitial lung disease with pleural effusion caused by simvastin. J Intern Med 1996, 239:361-363.
76. Rodriguez-Panadero F, Borderas Naranjo F, Lopez Mejias J: Benign pleural effusions in cancer patients. Frequency and etiopathogenic mechanism in a series of autopsy case. Rev Clin Esp 1988, 183:311-312.
77. Workshop Summary NHLBI: Report of workshop on lymphangioleiomyomatosis. National Heart, Lung, and Blood Institute. Am J Respir Crit Care Med 1999, 159:679-683.
78. Kalassian KG, Doyle R, Kao P, et al.: Lymphangioleiomyomatosis: new insights. Am J Respir Crit Care Med 1997, 155:1183-1186.
79. Kelly J, Moss J: Lymphangioleiomyomatosis. Am J Med Sci 2001, 321:17-25.
80. Taylor JR, Ryu J, Colby TV, Raffin TA: Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med 1990, 323:1254-1260.
81. Johnson S: Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax 1999, 54:254-264.
82. Matsui K, Takeda K, Yu ZX, et al.: Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study. Am J Respir Crit Care Med 2000, 161:1002-1009.
83. Eliasson AH, Phillips YY, Tenholder MF: Treatment of lymphangioleiomyomatosis. A meta-analysis. Chest 1989, 96:1352-1355.
84. Ryu JH, Doerr CH, Fisher SD, et al.: Chylothorax in lymphangioleiomyomato sis. Chest 2003, 123:623-627. This article provides an authoritative approach to managing this difficult condition.
85. Boehler A, Speich R, Russi EW, Weder W: Lung transplantation for lymphangioleiomyomatosis. N Engl J Med 1996, 335:1275-1280.
86. Vassallo R, Ryu JH, Schroeder DR, et al.: Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med 2002, 346:484-490. The only comprehensive statement that provides information of the natural history of this disease in adults.
87. Mendez JL, Nadrous HF, Vassallo R, et al.: Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest 2004, 125:1028-1032. This article reviews the natural history and management of pneumothorax in pulmonary Langerhans cell histiocytosis.
88. Guardia J, Pedreira JD, Esteban R, et al.: Early pleural effusion in histiocytosis X. Arch Intern Med 1979, 139:934-936.
89. Tittel PW, Winkler CF: Chronic recurrent pleural effusion in adult histiocytosis-X. Br J Radiol 1981, 54:68-69.
90. Winkler CF, Yam LT: Pleural effusion in histiocytosis X. Arch Intern Med 1980, 140:988.
91. Nagaoka S, Maruyama R, Koike M, et al.: Cytology of Langerhans cell histiocytosis in effusions: a case report. Acta Cytol 1996, 40:563-566.
92. Utz JP, Swensen SJ, Gertz MA: Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993. Ann Intern Med 1996, 124:407-413.
93. Samman YS, Wali SO, Abdelaal MA, et al.: Chronic eosinophilic pneumonia presenting with recurrent massive bilateral pleural effusion: case report. Chest 2001, 119:968-970.
94. d'Amours P, Leblanc P, Boulet LP: Chronic eosinophilic pneumonia associated with thrombocytosis and pleural effusion. CMAJ 1990, 142:837-839.